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Structural basis of the oligomerization of hepatitis delta antigen
Harmon J Zuccola1, James E Rozzelle2, Stanley M Lemon3, Bruce W Erickson2
and James M Hogle1,4*
Background: The hepatitis D virus (HDV) is a small satellite virus of hepatitis B
virus (HBV). Coinfection with HBV and HDV causes severe liver disease in
humans. The small 195 amino-acid form of the hepatitis delta antigen (HDAg)
functions as a trans activator of HDV replication. A larger form of the protein
containing a 19 amino acid C-terminal extension inhibits viral replication. Both of
these functions are mediated in part by a stretch of amino acids predicted to form
a coiled coil (residues 13–48) that is common to both forms. It is believed that
HDAg forms dimers and higher ordered structures through this coiled-coil region. 
Results: The high-resolution crystal structure of a synthetic peptide
corresponding to residues 12 to 60 of HDAg has been solved. The peptide
forms an antiparallel coiled coil, with hydrophobic residues near the termini of
each peptide forming an extensive hydrophobic core with residues C-terminal to
the coiled-coil domain in the dimer protein. The structure shows how HDAg
forms dimers, but also shows the dimers forming an octamer that forms a 50 Å
ring lined with basic sidechains. This is confirmed by cross-linking studies of
full-length recombinant small HDAg.
Conclusions: HDAg dimerizes through an antiparallel coiled coil. Dimers then
associate further to form octamers through residues in the coiled-coil domain and
residues C-terminal to this region. Our findings suggest that the structure of
HDAg represents a previously unseen organization of a nucleocapsid protein and
raise the possibility that the N terminus may play a role in binding the viral RNA.
Introduction
Coinfection of hepatitis D virus (HDV) with hepatitis B
virus (HBV) causes severe, and often fatal, liver disease in
humans, and is the most common cause of fulminant viral
hepatitis [1]. The virus is a subviral satellite of HBV,
requiring the hepatitis B surface antigen (HBsAg) for
assembly and cell-to-cell transmission [2]. The viral genome
can replicate in the absence of HBV, however [3]. The
viral genome is a 1.7 kilobase single-stranded circular RNA,
which is approximately 70% complementary to itself [4]
and forms a rod-like structure [5]. The virus is believed to
replicate by a double rolling-circle mechanism in infected
cells [6]. Both the genomic and antigenomic strands of the
virus contain ribozymes [7–10] which are responsible for the
reduction of multimeric viral genomes into unit length and
for directing the religation of the linear genomes [11]. The
antigenomic strand of the genome encodes the only viral
protein known to be associated with HDV, the hepatitis
delta antigen (HDAg) [4,12]. 
Early in the life cycle of the virus HDAg is expressed as a
195 amino-acid protein, the small hepatitis delta antigen
(HDAg-S), which functions as a transactivator of HDV
RNA replication [3]. Later in the life cycle of the virus,
there is an RNA editing event that changes the UAG stop
codon of the HDAg-S sequence to a UGG codon, encod-
ing a tryptophan. This allows translation to proceed for an
additional 19 amino acids, resulting in a 214 amino-acid
form of the protein, the large delta antigen (HDAg-L).
HDAg-L is a potent inhibitor of HDV replication [13,14]
and is also involved in packaging the viral RNA [15–17]
and the copackaging of the small antigen into the viral par-
ticle [15,17,18]. Both the large and small antigens are
highly specific RNA-binding phosphoproteins [19,20], and
have been shown to recognize specifically the viral rod-
like structure of the HDV viral genomes [21]. Cross-linking
studies have shown that both proteins can exist as either
homomultimers (all small antigen or all large antigen) or as
heteromultimeric structures (a mixture of small and large
antigen) [22–24].
There have been a number of structure–function studies of
both the large and small delta antigens. The N-terminal
one third of HDAg contains a putative coiled-coil sequence
[22–24], which is followed by a bipartite nuclear localization
signal [25]. The middle portion of HDAg contains two argi-
nine-rich motifs that have been shown to bind to the viral
RNA [26]. The C-terminal segment of HDAg-S is proline-
and glycine-rich [27]. HDAg-L is prenylated at the extreme
C terminus [28,29], and it is believed that this part of the
Addresses:  1Department of Biological Chemistry
and Molecular Pharmacology, Harvard Medical
School, 240 Longwood Avenue, Boston, MA
02115, USA, 2Department of Chemistry, The
University of North Carolina at Chapel Hill, Chapel
Hill, NC 27599, USA, 3Department of Microbiology
and Immunology, The University of Texas Medical
Branch at Galveston, Galveston, TX 77555-1019,
USA and 4Committee on Higher Degrees in
Biophysics, Harvard University, 240 Longwood
Avenue, Boston, MA 02115, USA.
*Corresponding author.
E-mail:  hogle@hogles.med.harvard.edu
Key words: coiled coil, delta antigen, hepatitis D,
leucine zipper
Received:  23 March 1998
Revisions requested:  23 April 1998
Revisions received:  6 May 1998
Accepted:  6 May 1998
Structure 15 July 1998, 6:821–830
http://biomednet.com/elecref/0969212600600821
© Current Biology Ltd ISSN 0969-2126
Research Article 821
molecule interacts with HBsAg and the membranes of the
endoplasmic reticulum [30,31]. There is also some evidence
that common segments of the large and small antigens may
have subtly different conformations [32,33].
The coiled-coil domain has been shown to be required for
a number of the functions of both small and large delta
antigens. Mutations that destroy or alter the coiled-coil
domain either greatly reduce or totally eliminate the
ability of HDAg-S to function as a trans activator of
replication [18,22]. These same mutations also prevent
HDAg-L from inhibiting HDV RNA replication and
inhibit its function in mediating the copackaging of
HDAg-S [18,22]. Transfection of cells undergoing HDV
replication with a plasmid containing just the N-terminal
one-third of HDAg (which contains the coiled-coil
domain) inhibited HDV replication [22]. But removal of
the coiled-coil domain does not prevent HDAg from
binding the viral RNA [20], nor does it prevent HDAg-L
from packaging the viral RNA [34]. A ‘black sheep’ model
has been proposed for the mechanism of inhibition of
HDV replication. HDAg-L is believed to disrupt the
homo-oligomeric HDAg-S multimers, essentially ‘poison-
ing’ the HDAg-S complex [22]. Although the precise role
of HDAg-S in replication of HDV is unknown, the protein
is not a polymerase: HDV RNA amplification is thought to
be mediated by host-cell RNA polymerase II [35,36].
Biophysical studies were undertaken to examine the
coiled-coil domain of HDAg [37]. A peptide was syn-
thesized that corresponds to residues 12–60 of HDAg,
referred to here as δ12–60(Y). The peptide also included
a C-terminal tyrosine, so that the peptide could be labeled
with I125 for use in a radioimmunoassay. The peptide
sequence was conceptually divided into three segments
based on the presence of two potential helix breakers,
Gly23 and Pro49: segments A (residues 12–24), B (residues
25–49), and C (residues 50–60); see Figure 1. The full-
length peptide δ12–60(Y) and two shorter peptides that
corresponded to regions A+B and B+C were synthesized.
A number of biophysical experiments, including circular
dichroism (CD), mass spectrometry, and analytical ultra-
centrifugation, clearly showed that the δ12–60(Y) peptide
was largely helical and formed a coiled coil [37]. The
shorter peptides formed much less stable structures and
were considerably less helical than δ12–60(Y). Human
polyclonal antibodies from hemophilic patients who were
chronic carriers of HBV and HDV reacted with the
δ12–60(Y) peptide in both an ELISA and a sandwich
radioimmunoassay [37,38]. Subsequent studies indicated
that monoclonal antibodies against the peptide recog-
nized a conformational epitope only presented by the
full-length peptide and not the shorter, extensively over-
lapping peptides [37].
We describe here the crystal structure of the peptide
δ12–60(Y) to 1.8 Å resolution. The structure of the peptide
lends new insights into the mechanism by which HDAg
dimerizes and further associates into higher ordered struc-
tures. The structure also explains why residues C-terminal
to the predicted coiled-coil domain, and the helix-breaking
proline residues are important for the stabilization of the
coiled-coil structure. The peptide structure has important
consequences for the oligomerization of HDAg in vivo. The
unique octameric structure observed in the crystal structure
also suggests that the N terminus of the molecule may have
a previously undetermined function.
Results
Structure determination
Attempts to find a heavy atom derivative using the peptide
with the wild-type sequence of the American strain of
HDAg failed. Thus, a new peptide was synthesized with
a cysteine replacing Ser22 (this residue demonstrates
considerable variation among different strains of HDV;
Figure 1). The cysteine-mutant and wild-type peptides
crystallized isomorphously. The presence of Cys22 allowed
the preparation of a platinum terpyridine derivative, facili-
tating the determination of the structure using single iso-
morphous replacement with anomalous scattering (SIRAS)
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Figure 1
Sequence alignment of ten serotypes of
HDAg between amino acids 12 and 60.
Residues marked with an asterisk make up the
a and d positions in the heptad repeat in the
predicted coiled-coil region. Bold residues in
pink and purple are involved in the
hydrophobic interactions in the dimer
between the two termini. The residues marked
with ‘d’ are involved in the dimer–dimer
interface. A (pink), B (green) and C (purple)
represent the sequence segments described
in the text.
HDVAM  GREDILEQWVSGRKKLEELERDLRKLKKKIKKLEEDNP GNIKGIIGK
HDVL1  GREEVLEQWVNSRKKAEELERDLRKTKKKIKKLEDDNP GNIKGILGK
HDVD3  GREEVLEQWVSGRKKLEELERDLRKVKKKIKKLEDEHP GNIKGILGK
HDVNA  GREEVLEQWVAGRRKQEELERDLRKTKKKIKKLEEENP GNIKGILGK
HDVS1  TREETLEKWITARKKAEELEKDLRKTRKTIKKLEEENP GNIVGII.R
HDVS2  TREETLEKWITARKKAEELEKDLRKARKTIKKLEEENP GNILGII.R
HDVM1  GREQILEQWVDGRKKLEELERDLRKIKKKIKKLEEENP GNVKGILGK
HDVM2  GREQILEQWVDGRKKLEELERDLRKIKKKIKKLEEENP GNVKGILGK
HDVIT  GREEILEQWVAGRKKLEELERDLRKTKKKLKKIEDENP GNIKGILGK
HDVWO  GREEILEQWVAGRKKLEELERDLRKTKKKLKKIEDENP GNIKGILGK
           *d  *d *   *  *   *  *   *  *   * d   d   d
A B C
12 25 49 60
Structure
methods (Table 1). Retrospective examination of the
model confirmed that the Pt was indeed bound to the
sulfur of Cys22.
The solvent-flattened map was easily interpretable, and
clearly showed two dimers in the asymmetric unit. Rounds
of positional refinement, simulated annealing, tempera-
ture factor refinement using X-PLOR [39], and manual
rebuilding using O [40] led to the current model (Table 2,
Figure 2). The current model has an R factor of 22.5% and
a free R factor of 27% with good geometry (root mean
square deviation [rmsd] bond 0.007 Å and rmsd bond
angles 1.0°). A number of sidechains exposed to the large
solvent channel, as well as the first residue in the chain
and the last residue in one of the chains, are disordered.
The four monomers in the asymmetric unit superimpose
well onto one another, with an average rmsd for mainchain
atoms of 0.81 Å and for all non-hydrogen atoms 1.51 Å.
The main differences in the monomers are those residues
involved in crystal packing interactions.
Structure description
Each monomer is composed of a long, N-terminal helix,
approximately 60 Å in length, interrupted by a sharp bend
at Pro49, and continuing on into another short helix. The
long helices of each of two monomers wrap around each
other forming an antiparallel coiled coil (Figure 3a,b),
which straightens out at the N terminus. Only one of the
four possible salt bridges between Glu31 and Lys38 is seen.
In the other three cases, the charged groups are slightly
farther apart (3.8 Å, 4.2 Å and 4.4 Å) and the sidechains
are hydrogen-bonded to nearby solvent molecules. The
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Table 1
Data collection statistics.
Native* S22C Pt 
Spacegroup P21212 P21212
Unit cell (a, b, c) 109.2, 85.3, 29.4 110.3, 86.3, 29.6
Temperature of 
data collection (°C) –160 –165
Resolution (Å) 15–1.73 86–2.5
Number of reflections 221,286 44,362
Number of unique reflections 28,279 10,013
Completeness† (%) 94 (35) 97
I/σ† 51 (7) 6.0
Multiplicity 7.8 4.4
Rsym†‡§ (%) 4.2 (18) 6.7 [14.0]
Riso¶ (%) – 30.5
Rcullis# – 0.62 (0.52)
Rcullis anom¥ – 0.84
Phasing power** – 2.2 (1.7)
*Data are from two crystals. †Numbers in parentheses represent values
in the highest resolution shell. ‡Rsym = Σ(h,k,l) | I (h,k,l)– < I(h,k,l) > | / Σ(h,k,l)
< I(h,k,l) >, where < I(h,k,l) > represents the sigma-weighted average
intensity of symmetry-equivalent reflections. §The number in square
brackets represents Ranom = Σ | < I+(h,k,l) >–< I–(h,k,l) > | / Σ (< I+(h,k,l) > +
< I–(h,k,l) >), where < I+/–(h,k,l) > represents the statistically weighted
average intensity of symmetry-equivalent reflections. ¶Riso = Σ(h,k,l) |
(FPH–FP) | / Σ(FP). #Rcullis = Σ(h,k,l) | | FPH| – |FP + FH| | / Σ(h,k,l)| FPH–FP |;
number in parentheses represent Rcullis for centric reflections. ¥Rcullis
anom = Σ(h,k,l) | | FPH+ – FPH–|obsvd– |FPH+ – FPH– |calc /Σ(h,k,l)| FPH+–FPH– |obsvd.
**Phasing power = < |FH| / | |FPH| – |FP + FH| | >; the number in
parentheses is the phasing power for centric reflections.
Figure 2
The final atomic model superimposed upon a
portion of the final 1.8 Å resolution X-PLOR
2Fo–Fc map. The map is contoured at 1.2σ
and shows the residues involved in the
interaction between monomers at the A and C
regions. The orientation is similar to that in
Figure 4. (The figure was produced using the
program BOBSCRIPT.)
Table 2
Refinement statistics.
Resolution range (Å) 15–1.8
Rworking* (%) 22.5
Rfree† (%) 27.0
Non-hydrogen protein atoms 1785
Solvent atoms 114
Rms from ideal geometry
bond lengths (Å) 0.007
bond angles (°) 1.0
dihedral angles (°) 16.9
impropers (°) 0.59
Average B factor overall (Å2) 29.3
mainchain 22.5
sidechain 32.4
solvent 34.7
*Rworking = Σ(h,k,l) | (|Fo|–|Fc|) | / Σ(Fo), for a working set composed of
90% of the data. †Rfree = Σ(h,k,l) | (|Fo|–|Fc|) | / Σ(Fo), for a test set
composed of 10% of the data selected randomly.
sidechain of Glu45 is hydrogen-bonded to the indole
nitrogen of Trp20. The sidechain of Asn48, which is
located at the C terminus of the long helix, completes
the hydrogen-bonding pattern of the helix by making a
hydrogen bond back to the mainchain oxygen of Leu44.
The formation of the dimer buries 2650 Å2 of surface area,
approximately 26% of the total surface area.
Although the majority of residues in the heptad repeat
(Figure 3c) of the predicted coiled-coil region do pack as
expected, Trp20 does not. Instead, the sidechain of Trp20
is flipped away from the core of the coiled coil and into a
hydrophobic region formed between segment A (residues
12–24) of one monomer, and segment C (residues 50–60) of
its partner within the peptide dimer. The dimer shows pri-
marily hydrophobic interactions between residues in the A
and C regions. Ile16, Leu17, Trp20, Trp50, and Leu51 are
the sidechains primarily involved in this hydrophobic region,
which is capped by the aliphatic portion of the sidechains of
Arg13 and Arg24 (Figure 4). The primary non-hydrophobic,
monomer–monomer interactions near this region involve
the formation of a hydrogen bond between Trp20 and
Glu45 (Figure 4). The heptad repeat is also unusual in that
it contains a glycine at position 23. If the monomers were
oriented in a parallel fashion, a large ‘hole’ in the middle of
the hydrophobic core of the dimer would result. But as the
strands are antiparallel, the large sidechain of Ile41 packs
into the hole formed by Gly23. 
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Figure 3
Overall organization of the HDAg dimer. 
(a) Cα trace of the peptide δ12–60(Y). The
three regions of the peptide are color-coded:
A pink; B green; and C purple. The two
monomers form an antiparallel coiled coil. The
individual helix takes a sharp bend at Pro49.
(b) Ribbon diagram of the view in (a) rotated
90° along the horizontal axis. The sidechains
have been added and the C region of the
peptide (residues 50–60(Y)) has been
removed for clarity. Sidechains are color-
coded: hydrophobic, gray; polar, yellow;
acidic, red; and basic, blue. Although the
majority of the hydrophobic sidechains are
packed in the interior of the coiled coil, Trp20
is flipped out of the core of the long helix. The
figure also illustrates that the two helices
clearly wrap around one another. (c) The
amino-acid sequence of the long helix formed
from residues 12–48 displayed in the
antiparallel orientation of the peptide. The
letters above the amino-acid sequence
represent the heptad repeat (abcdefg)n where
the a and d residues tend to be hydrophobic.
Residues involved in the heptad repeat at the
a and d positions are shown in bold.
   12                                  48
    gabcdefgabcdefgabcdefgabcdefgabcdefga
   GREDILEQWVSGRKKLEELERDLRKLKKKIKKLEEDN
       NDEELKKIKKKLKRLDRELEELKKRGSVWQELIDERG
       agfedcbagfedcbagfedcbagfedcbagfedcbag
        48                                            12
(a)
(b)
(c)
Structure
In the crystal, each dimer associates with three other
dimers to form a doughnut-like octamer (Figure 5). The
octamer is widely open with a central ‘hole’, 50 Å in diam-
eter. The open structure of the octamer is reminiscent of
several other proteins, including that of proliferating cell
nuclear antigen (PCNA), in which the hole that is formed
is believed to encircle DNA [41]. It is this octameric struc-
ture which is the translational repeating unit in the crystal
(Figure 5). The dimer–dimer interface is a four-helix
bundle formed across the crystallographic twofold axis.
The interface of the two dimers consists of hydrophobic
residues in region A of the coiled-coil domain (Leu17 and
Val21), but also includes residues C-terminal to the coiled-
coil domain, region C, between residues 50 and 60 (Trp50,
Ile54, Ile57 and Ile58; Figure 6), essentially extending the
hydrophobic core mentioned above. Trp50 is involved in
the formation of both the dimer and the octamer. Forma-
tion of the octamer buries an additional 800 Å2 of surface
area per monomer, which means that approximately 40%
of the total surface area of each monomer is buried. The
50 Å diameter hole framed by the four dimers is lined with
basic sidechains (Figure 7).
Mass spectrometry
Previous studies have suggested that both the peptide
and natural HDAg derived from infected liver form
multimers in solution [23,37]. In order to investigate the
significance of the octamer formed by the peptide,
MALDI-TOF mass spectrometry was used to determine
the mass of monomeric and oligomeric forms of recombi-
nant small delta antigen, rHDAg-S. The uncross-linked
protein has a mass of 21,832 Da (Figure 8a), which is the
correct mass (within 0.01%) of the amino-acid sequence
of the American strain of HDAg-S (Genbank accession
number M28267) minus the first methionine residue.
The primary species of the cross-linked rHDAg-S had a
mass of 176,282 Da (Figure 8b). Indeed, the M+1 and
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Figure 4
The dimer is stabilized by hydrophobic
interactions other than those provided by
residues in the heptad repeat. Residues from
the N termini of each monomer, Ile16, Leu17
and Trp20 from one monomer and Trp50,
Leu51 and Ile54 from the other, form a
hydrophobic core which is protected from
solvent by the aliphatic portions of Arg13 and
Arg24. There is also a hydrogen bond
between the sidechain of Glu45 and the
indole nitrogen of Trp20 (O–N distance
2.8 Å). The three regions of the peptide are
color-coded: A pink; B green; and C purple.
(This figure was produced using the program
RIBBONS [58].)
Figure 5
The interactions of dimers in the P21212 unit cell. The unit cell is
outlined in black and the directions of the a and b axes are shown.
Four dimers come together to form an octameric complex forming a
pseudo-centered (C222) cell. The two independent copies of the
dimer in the asymmetric unit are colored orange and blue. The view is
looking down the crystallographic twofold axis. (This figure was
produced using the program MOLSCRIPT [59].)
M+2 peaks of the octamer were the only significant
peaks in the spectrum. The ratio of the masses of the
cross-linked species to the monomer is 8.1:1. 
Discussion
Oligomerization of HDAg
The structure of the δ12–60(Y) peptide raises a number
of interesting questions about the function of the coiled-
coil domain of HDAg. When the HDAg open reading
frame was originally examined, amino acids from residue
13 to 47 were identified as possibly forming a coiled coil.
Glutaraldehyde cross-linking studies of full-length HDAg,
as well as of the peptide, confirmed the formation of
dimers, tetramers and higher-ordered structures [23,37].
The crystal structure of the peptide clearly shows how
monomers come together to form antiparallel dimers as
well as a higher-ordered octameric structure. The struc-
ture of δ12–60(Y) also agrees well with previous CD
studies of the peptide, which indicated that the two ends
of the peptide (regions A and C) were important for the
structural stability of the coiled coil [37]. Shorter synthe-
sized peptides that were missing either the A or C regions
(A+B and B+C) were significantly less helical than the
full-length peptide (A+B+C; 37%, 45% and 84% respec-
tively at 37°C). The peptide structure shows that hydro-
phobic residues from the N terminus of one monomer
(region A), not involved in the heptad repeat, interact
with residues outside of the predicted coiled-coil domain
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Figure 6
The dimer–dimer interface extends the
hydrophobic core formed by the ends of the
two monomers. (a) The dimer–dimer interface
is composed of a four-helix bundle made from
the N and C termini of two dimers, one from
across the crystallographic twofold axis.
Hydrophobic residues from the four helices
pack in the interface, Leu17, Val21, Trp50,
Ile54, Ile57 and Ile58. For clarity, one
(unlabeled) dimer has been colored yellow
and the other (labeled) dimer is colored
according to the scheme used in Figure 1. 
(b) The view in (a) rotated 90° around the
y axis. (This figure was created with the
program RIBBONS [58].)
Figure 7
Solvent-accessible surface showing
electrostatic potential of the HDAg octamer.
(a) A GRASP electrostatic potential surface
of the octameric δ12–60(Y) peptide
contoured at = 10 kT/e (positive potential
blue) and = 10 kT/e (negative potential red).
Residues Lys26 and Lys38, which had been
modeled as alanine, were changed to lysine
for this calculation. The edges and the lining
of the large 50 Å hole are basic. (b) The hole
formed by the octamer is large enough to
accommodate an RNA molecule. (The
electrostatic surface was calculated using the
program GRASP [60] and rendered using
RASTER3D [61].)
near the C terminus of the other monomer (region C) to
form a hydrophobic core (Trp20, Leu24, Trp50, Leu51)
sandwiched between Arg13 and Arg24. This may stabi-
lize the structure by keeping the ends of the helix from
fraying. An additional stabilizing feature is a hydrogen
bond between the sidechain of Glu45 and the indole
nitrogen of Trp20. These hydrophobic residues, as well
as the glutamic acid residue, are highly conserved in the
11 different strains of HDV identified to date (Figure 1).
In fact, they are more conserved than those residues in
the heptad repeat making up the hydrophobic core of the
long helix (Figure 1).
The observation that rHDAg-S forms octamers means that
the octamer form seen in the crystal may not be an artifact
of crystallization, but rather may represent the true state of
the oligomerization of the delta antigen. A study by Chang
and colleagues found that a deletion in HDAg-L, just
C-terminal to the coiled-coil domain (residues 50–75), pre-
vented HDAg-S from being copackaged with HDAg-L
[42]. HDAg-L with this same deletion could not inhibit
HDV replication, whereas a deletion in HDAg-L of residues
65 to 75 could. This suggested that the coiled-coil domain
alone is not sufficient for the interaction between the large
and small antigens, and that a subdomain between residues
50 and 65 is also necessary for this interaction. The crystal
structure of δ12–60(Y) indeed shows the importance of
residues between 50 and 60 in the formation of the peptide
oligomer. They are not only involved in stabilizing the
δ12–60(Y) dimer (Trp50 and Leu51), but are also involved
in the formation of the dimer–dimer interface (Trp50,
Ile54, and Ile58).
Black sheep model revisited
Before the studies described here, the overall organization
of the HDAg oligomer was unknown. Lai and coworkers
[22], inferring from previous data that showed that as little
as 12% of HDAg-L is needed to inhibit 90% of viral activity
[13], proposed that as little as one part of HDAg-L in eight
parts of HDAg-S could inhibit viral replication. Their black
sheep model proposed that HDAg-L either disrupted the
conformation of the oligomer of HDAg-S, therefore pre-
venting it from binding to host factors, or that the presence
of HDAg-L in the complex prevents the complex from
interacting with host factors. This would seem in agree-
ment with the peptide structure of octameric δ12–60(Y) and
the results of the MALDI-TOF analysis.
If HDAg-L does disrupt the conformation of the oligomer
of HDAg-S, it probably does not do so directly through
the multimerization domain, given that the large and
small delta antigens share the same sequence within this
region. Rather, it is possible that this α7β or αnβm struc-
ture can no longer interact with host factors. Also, as the
C terminus of HDAg-L interacts with the endoplasmic
reticulum (ER) membrane and with HBsAg for assembly,
it could redirect the complex elsewhere in the cell, pre-
venting the nuclear translocation of HDAg-S which is
required for HDV replication.
Possible undetermined functions of the N terminus
The octamer that is formed by the peptide is reminiscent
of proteins that form clamps around DNA, such as PCNA
[41]. The 50 Å hole formed by the octameric structure is
lined with basic sidechains, suggesting that the N termi-
nus of the protein not only may act as a dimerization/
oligomerization domain, but also that it may function
either as a clamp around the viral RNA or other nucleic
acid or perhaps even function as a spool for nucleic acid.
There is a report that peptides corresponding to the extreme
N-terminal portion of HDAg, residues 2 to 27 and 2 to 17,
can bind the viral RNA [43,44]. As the δ12–60(Y) structure
is missing residues 2 to 11, it is impossible to say what role
they play in binding the viral RNA. Of the remaining
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Figure 8
MALDI-TOF analysis of (a) rHDAg-S and (b) the glutaraldehyde cross-
linked protein. The protein was prepared as described in the Materials
and methods section. 
(a)
(b)
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residues, only Lys25 and Lys26, which point into the hole
of the octamer, seem likely to play a role in binding RNA
by potentially binding the phosphate backbone of the
viral RNA.
The large size of the hole may be necessary to accommo-
date the viral RNA which is only 70% self-complemen-
tary, and would possess a number of regions of bulged out
single-stranded sequence, increasing the radius of gyration
of the RNA as well as bending the RNA [45]. The octameric
structure also implies that there may be as many as four
RNA-binding domains on each side of the octamer,
although the exact consequences of such an arrangement
is presently unclear. It is possible that this portion of the
molecule could also bind another protein, especially one
that is acidic, such as the recently discovered delta antigen
interacting protein A (dipA), a cellular protein of unknown
function which has been found to interact with HDAg [46]
and, based on its amino-acid sequence, would have an iso-
electric point of 4.9.
A cautionary tale
Many investigators referred to the putative coiled-coil
domain of the delta antigen as a leucine-zipper-like region.
Experiments involving mutations in this region were
interpreted assuming the coiled-coil domain of the delta
antigen would resemble the parallel coiled coil of the
bZIP family of transcription factors, such as GCN4. Along
with the structure of the δ12–60(Y) peptide, there are
other examples of molecules that dimerize through anti-
parallel coiled-coil domains, such as the Escherichia coli
regulatory protein, AraC [47], and the replication termi-
nator protein from Bacillus subtilis [48]. Although algo-
rithms have been designed to determine the oligomer-
ization state of a coiled coil [49,50], no program yet exists
that attempts to determine the orientation of the pre-
dicted coiled coil. The discovery that this region forms
an antiparallel coiled coil should be a reminder that
without further biochemical or genetic evidence, a pre-
dicted coiled-coil domain may adopt either a parallel or
antiparallel conformation.
Biological implications
The hepatitis delta antigen (HDAg), the sole protein made
by the hepatitis delta virus (HDV), is essential for viral
replication in vivo. Oligomerization of the protein is nec-
essary for both the transactivating function of the small
HDAg-S and the trans dominant inhibitory effect of the
large HDAg-L. The structure of the peptide δ12–60(Y)
that corresponds to the predicted coiled-coil domain of
HDAg suggests that HDAg not only dimerizes through
an antiparallel coiled coil but also forms octamers. Inter-
estingly, the coiled coil is stabilized by hydrophobic
residues C-terminal to the coiled-coil domain. These C-ter-
minal residues interact with hydrophobic residues in the
N terminus of the coiled-coil region. The hydrophobic
core of the dimer is extended by further hydrophobic inter-
actions at the interface between dimers in the octameric
structure. In contrast to the rather promiscuous interac-
tions between the coiled-coil domain, these unique interac-
tions at the termini of the monomer and dimer interfaces
might provide a good target for antivirals against HDV, as
disruption of oligomerization can prevent replication in
vivo.
The surprising octameric structure of the peptide sug-
gests that the capsid of HDAg will look very different to
the known structures of other viral nucleocapsid pro-
teins. The octameric structure also suggests important
implications for binding of HDAg to the viral RNA,
because as many as four of the arginine-rich RNA-
binding domains might be needed for binding to the viral
RNA. The very basic hole in the octamer suggests that
this portion of the molecule may act as a sort of
‘clamp’ around an acidic molecule; whether that mol-
ecule is the viral RNA, some other nucleic acid or a cel-
lular factor has yet to be determined.
The exact function of HDAg in viral replication is still
unclear. It has been suggested that the protein may only
function as a shuttle, binding to the viral RNA and
transporting it into the nucleus of the infected cell. It is
possible that HDAg functions to recruit host cell
transcriptional machinery to the viral RNA, but no such
interaction has yet been identified. With the structure in
hand, it should be possible to design experiments to
further explore the possibility that the N terminus of the
molecule has RNA-binding capabilities. A systematic
examination of the amino acids involved in dimerization
and oligomerization may allow the determination of the
mechanism by which HDAg-L inhibits HDAg-S. Fur-
thermore, the unique interactions at the termini of the
coiled-coil region may provide a new framework to be
exploited in the de novo design of stable antiparallel
coiled coils.
Materials and methods
Crystallization and data collection
The δ12–60(Y) peptide was synthesized and purified as described
previously [37]. The peptide was dissolved in 50 mM acetate, pH 4.8,
50 mM NaCl and brought to a concentration of 15 mg/ml. The crystals
of the δ12–60(Y) peptide were grown at 22°C by the vapor diffusion
method. Peptide (2 µl of a 15 mg/ml solution) was mixed with 2 µl of
the reservoir solution containing 100 mM sodium acetate, pH 4.8, and
100 mM sodium citrate, pH 5.6, on a coverslip and then inverted over
the reservoir solution. Crystals appeared within 3–4 days, and grew as
large as 0.5 × 0.3 × 0.3 mm. Crystals belonged to space group
P21212 with unit cell parameters a = 109.3 Å, b = 85.3 Å, c = 29.4 Å,
α = β = γ = 90°. When attempts to find a heavy atom derivative failed,
a peptide was synthesized with Ser22 replaced by a cysteine,
δS22C12–60(Y). The δS22C12–60(Y) peptide was reacted with an
excess of platinum terpyridine, dialyzed overnight against water, and
then freeze dried. The peptide was then reconstituted at 15 mg/ml in
50 mM acetate, 50 mM NaCl, 5 mM DTT, pH 4.8, and crystallized by
the same conditions as that of the wild-type peptide. This peptide
crystallized isomorphously with the δ12–60(Y).
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The coverslips containing the crystals were inverted and cryosolvent
(reservoir solution containing 30% glycerol) was slowly mixed with the
drops and continuously replaced until no mixing was observed. The
crystals were mounted in nylon loops and frozen directly in the nitrogen
stream. Crystals used at Brookhaven were stored in liquid nitrogen until
the time of data collection. Two native data sets were collected at
Beamline X12C at the National Synchrotron Light Source at
Brookhaven National Laboratory using X-rays of wavelength 1.15 Å
(Table 1). The heavy atom data set was collected on a Siemens rotating
anode with a multiwire detector (Table 1). Data from the native crystals
were processed using DENZO [51] and SCALEPACK. Data from the
heavy atom derivative were integrated using the program BUDDHA [52]
and processed using ROTAVATA and AGROVATA from the CCP4
package [53]. Structure factors from both data sets were calculated
using TRUNCATE [53]. Data from the native and derivative were scaled
together using SCALEIT [53].
Structure determination and model building 
The positions of the heavy atom sites were determined using SHELXS-
86 [54]. The positions of the heavy atom sites were refined using
MLPHARE [55] and initial SIRAS phases were calculated. The data
was then subjected to a round of solvent flattening with histogram
matching using DM [56]. A map was calculated which clearly showed
the position of the two dimers in the asymmetric unit, and an initial
model was built into the initial SIRAS map using the program O [40].
The structure was refined using X-PLOR v3.8.9 [39]. Rounds of posi-
tional refinement, followed by simulated annealing and B-factor refine-
ment, were carried out with rebuilding of the structure using O between
cycles of refinement. During the initial model building and refinement,
omit maps, which excluded 10 residues at a time, were used to check
the progress of refinement.
Surface and electrostatic calculations
Surface calculations were performed using the surface option in
QUANTA version 4.0. Electrostatic calculations were performed with
GRASP version 1.3.
Protein expression and purification
The pR5δV5 plasmid [57], which contains a synthetic gene for HDAg-S,
was transformed into E. coli BL21(DE3)pLysS cells (Novagen) and puri-
fied as described previously [57]. Briefly, 45 ml of frozen cells, corre-
sponding to three 1 l cultures, were thawed and one protease inhibitor
tablet (Boehringer Mannheim) was added, as well as RNAse A and
DNAse I to a final concentration of 50µg/ml. Cells lysed by sonication
were pelleted at 10,000 × g for 30 min. The lysate was diluted threefold
with 50 mM HEPES buffer, pH 7.5, and then applied to a 10× 1.5 cm
Fast SP Sepharose (Pharmacia) column equilibrated with 50 mM
HEPES buffer, pH 7.5, and eluted using a salt gradient from 0–1M NaCl
in 50 mM HEPES, pH 7.5. The fractions containing rHDAg-S were
assayed using sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) and pooled. The sample was then applied to a Superdex
S-200 column (Pharmacia) equilibrated with 50 mM Hepes, pH 7.5,
500 mM NaCl and 5% glycerol. The elution of the protein from the
column was monitored by UV absorbance at 280 nm.
Mass spectrometry
The rHDAg-S was prepared as described above. The samples for mass
spectrometry were prepared as follows: rHDAg-S was dialyzed
overnight against water. Cross-linked protein was prepared by the addi-
tion of 5 µl of 0.5% glutaraldehyde to 40 µl of rHDAg-S for 5 min, and
quenched by the addition of 5 µl of 1 M ammonium acetate. Mass spec-
trometry was performed in the BCMP Biopolymer facility on a Perscep-
tive Biosystems Voyager-DE mass spectrometer.
Accession numbers
The coordinates have been deposited in the Brookhaven Protein Data
Bank (accession number 1A92), and are available from the authors by
sending email requests to harmon@dag.med.harvard.edu.
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